Compile Data Set for Download or QSAR
Report error Found 14 of affinity data for UniProtKB/TrEMBL: Q9BZ11
TargetDisintegrin and metalloproteinase domain-containing protein 33(Human)
Galderma Research & Development

US Patent
LigandPNGBDBM125925(US8772478, 14)
Affinity DataIC50: 24nMpH: 7.4Assay Description:The products are solubilized in DMSO at a concentration of 10 mM. A serial 3-fold dilution over 10 points is carried out so as to have a concentratio...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetDisintegrin and metalloproteinase domain-containing protein 33(Human)
Galderma Research & Development

US Patent
LigandPNGBDBM125923(US8772478, 15 | US8772478, 8)
Affinity DataIC50: 26nMpH: 7.4Assay Description:The products are solubilized in DMSO at a concentration of 10 mM. A serial 3-fold dilution over 10 points is carried out so as to have a concentratio...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetDisintegrin and metalloproteinase domain-containing protein 33(Human)
Galderma Research & Development

US Patent
LigandPNGBDBM125925(US8772478, 14)
Affinity DataIC50: 38nMpH: 7.4Assay Description:The products are solubilized in DMSO at a concentration of 10 mM. A serial 3-fold dilution over 10 points is carried out so as to have a concentratio...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetDisintegrin and metalloproteinase domain-containing protein 33(Human)
Galderma Research & Development

US Patent
LigandPNGBDBM125923(US8772478, 15 | US8772478, 8)
Affinity DataIC50: 112nMpH: 7.4Assay Description:The products are solubilized in DMSO at a concentration of 10 mM. A serial 3-fold dilution over 10 points is carried out so as to have a concentratio...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetDisintegrin and metalloproteinase domain-containing protein 33(Human)
Galderma Research & Development

US Patent
LigandPNGBDBM125922(US8772478, 7)
Affinity DataIC50: 147nMpH: 7.4Assay Description:The products are solubilized in DMSO at a concentration of 10 mM. A serial 3-fold dilution over 10 points is carried out so as to have a concentratio...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetDisintegrin and metalloproteinase domain-containing protein 33(Human)
Galderma Research & Development

US Patent
LigandPNGBDBM125917(US8772478, 1)
Affinity DataIC50: 181nMpH: 7.4Assay Description:The products are solubilized in DMSO at a concentration of 10 mM. A serial 3-fold dilution over 10 points is carried out so as to have a concentratio...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetDisintegrin and metalloproteinase domain-containing protein 33(Human)
Galderma Research & Development

US Patent
LigandPNGBDBM125919(US8772478, 3)
Affinity DataIC50: 181nMpH: 7.4Assay Description:The products are solubilized in DMSO at a concentration of 10 mM. A serial 3-fold dilution over 10 points is carried out so as to have a concentratio...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetDisintegrin and metalloproteinase domain-containing protein 33(Human)
Galderma Research & Development

US Patent
LigandPNGBDBM125920(US8772478, 5)
Affinity DataIC50: 249nMpH: 7.4Assay Description:The products are solubilized in DMSO at a concentration of 10 mM. A serial 3-fold dilution over 10 points is carried out so as to have a concentratio...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetDisintegrin and metalloproteinase domain-containing protein 33(Human)
Galderma Research & Development

US Patent
LigandPNGBDBM125918(US8772478, 2)
Affinity DataIC50: 298nMpH: 7.4Assay Description:The products are solubilized in DMSO at a concentration of 10 mM. A serial 3-fold dilution over 10 points is carried out so as to have a concentratio...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetDisintegrin and metalloproteinase domain-containing protein 33(Human)
Galderma Research & Development

US Patent
LigandPNGBDBM125921(US8772478, 6)
Affinity DataIC50: 328nMpH: 7.4Assay Description:The products are solubilized in DMSO at a concentration of 10 mM. A serial 3-fold dilution over 10 points is carried out so as to have a concentratio...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetDisintegrin and metalloproteinase domain-containing protein 33(Human)
Galderma Research & Development

US Patent
LigandPNGBDBM125924(US8772478, 9)
Affinity DataIC50: 469nMpH: 7.4Assay Description:The products are solubilized in DMSO at a concentration of 10 mM. A serial 3-fold dilution over 10 points is carried out so as to have a concentratio...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetDisintegrin and metalloproteinase domain-containing protein 33(Human)
Galderma Research & Development

US Patent
LigandPNGBDBM50203527(methyl (6S,7S)-7-[(hydroxyamino)carbonyl]-6-[(4-ph...)
Affinity DataIC50: 1.03E+3nMAssay Description:Inhibition of ADAM33More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetDisintegrin and metalloproteinase domain-containing protein 33(Human)
Galderma Research & Development

US Patent
LigandPNGBDBM50265157((6S,7S)-N-hydroxy-5-methyl-6-(4-(5-(trifluoromethy...)
Affinity DataIC50: 4.13E+3nMAssay Description:Inhibition of ADAM33More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetDisintegrin and metalloproteinase domain-containing protein 33(Human)
Galderma Research & Development

US Patent
LigandPNGBDBM26526(BMCL181958 Compound 1 | CHEMBL148169 | (2R)-N-hydr...)
Affinity DataKi:  15nMAssay Description:Inhibition of ADAM33More data for this Ligand-Target Pair
In DepthDetails Article
PubMed